About viridian therapeutics inc - VRDN
Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
VRDN At a Glance
Viridian Therapeutics, Inc.
221 Crescent Street
Waltham, Massachusetts 02453
| Phone | 1-617-272-4600 | Revenue | 302.00K | |
| Industry | Pharmaceuticals: Major | Net Income | -208,560,000.00 | |
| Sector | Health Technology | Employees | 143 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
VRDN Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 4,309.177 |
| Price to Book Ratio | 3.216 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -2.672 |
| Enterprise Value to Sales | 2,634.991 |
| Total Debt to Enterprise Value | 0.029 |
VRDN Efficiency
| Revenue/Employee | 2,111.888 |
| Income Per Employee | -1,458,461.538 |
| Receivables Turnover | N/A |
| Total Asset Turnover | 0.00 |
VRDN Liquidity
| Current Ratio | 15.425 |
| Quick Ratio | 15.425 |
| Cash Ratio | 14.989 |
VRDN Profitability
| Gross Margin | -310.596 |
| Operating Margin | -99,018.212 |
| Pretax Margin | -89,387.086 |
| Net Margin | -69,059.603 |
| Return on Assets | -33.834 |
| Return on Equity | -37.455 |
| Return on Total Capital | -30.02 |
| Return on Invested Capital | -36.038 |
VRDN Capital Structure
| Total Debt to Total Equity | 3.439 |
| Total Debt to Total Capital | 3.324 |
| Total Debt to Total Assets | 3.111 |
| Long-Term Debt to Equity | 4.678 |
| Long-Term Debt to Total Capital | 3.25 |